Abstract:148 Frontline Therapy with the RiBVD Regimen Elicits High Clinical and Molecular Response Rates and Long PFS in Elderly Patients Mantle Cell Lymphoma (MCL); Final…
Slide 1 Recurrent Follicular Lymphoma With a Short First Remission: How Aggressive Should We Be? Carla Casulo, MD Wilmot Cancer Institute University of Rochester Medical…
New Agents in Management of Indolent B-Cell NHLs F B Hagemeister MD Department of Lymphoma/Myeloma M D Anderson Cancer Center Las Vegas, Nevada February 27, 2014 New Agents…
vervolg CASUS september 2009 inmiddels 6 kuren R-CVP ondergaan restadiering: PR EN NU? september 2009 watch and wait onderhoud rituximab autologe SCT onderhoud rituximab…
A Phase III Randomized Intergroup Trial (SWOG S0016) of CHOP Chemotherapy plus Rituximab vs CHOP Chemotherapy plus Iodine-131-Tositumomab for the Treatment of Newly Diagnosed…
Presentazione standard di PowerPoint Emanuele Zucca, MD Oncology Institute of Southern Switzerland (IOSI) Swiss Group for Clinical Cancer Research (SAKK) 1 Is there Long-Term…
New Agents in Management of Indolent B-Cell NHLs F B Hagemeister MD Department of Lymphoma/Myeloma M D Anderson Cancer Center Las Vegas, Nevada February 27, 2014 New Agents…